Literature DB >> 23819024

Epidemiology and prognosis of breast cancer in young women.

Hussein A Assi1, Katia E Khoury, Haifa Dbouk, Lana E Khalil, Tarek H Mouhieddine, Nagi S El Saghir.   

Abstract

Breast cancer is the most common malignancy in women with 6.6% of cases diagnosed in young women below the age of 40. Despite variances in risk factors, Age Standardized Incidence Rates of breast cancer in young women vary little between different countries. Review of modifiable risk factors shows that long-term use of oral contraceptives, low body mass index (BMI) and high animal fat diet consumption are associated with increased risk of premenopausal breast cancer. Decreased physical activity and obesity increase risks of breast cancer in postmenopausal women, but data on premenopausal women rather shows that high BMI is associated with decreased risk of breast cancer. Non-modifiable risk factors such as family history and genetic mutations do account for increased risks of breast cancer in premenopausal women. Breast cancer in young women is associated with adverse pathological factors, including high grade tumors, hormone receptor negativity, and HER2 overexpression. This has a significant negative impact on the rate of local recurrence and overall survival. Moreover, younger women often tend to present with breast cancer at a later stage than their older counterparts, which further explains worse outcome. Despite these factors, age per se is still being advocated as an independent role player in the prognosis. This entails more aggressive treatment modalities and the need for closer monitoring and follow-up.

Entities:  

Keywords:  Breast cancer; epidemiology; prognosis; young age

Year:  2013        PMID: 23819024      PMCID: PMC3695538          DOI: 10.3978/j.issn.2072-1439.2013.05.24

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  65 in total

Review 1.  Olive oil, an essential component of the Mediterranean diet, and breast cancer.

Authors:  Eduard Escrich; Raquel Moral; Montserrat Solanas
Journal:  Public Health Nutr       Date:  2011-12       Impact factor: 4.022

2.  Genetic implications of bilateral breast cancer: a population based cohort study.

Authors:  Mikael Hartman; Kamila Czene; Marie Reilly; Jonas Bergh; Pagona Lagiou; Dimitrios Trichopoulos; Hans-Olov Adami; Per Hall
Journal:  Lancet Oncol       Date:  2005-06       Impact factor: 41.316

3.  Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer.

Authors:  Peter C Dubsky; Michael F X Gnant; Susanne Taucher; Sebastian Roka; Daniela Kandioler; Barbara Pichler-Gebhard; Irene Agstner; Michael Seifert; Paul Sevelda; Raimund Jakesz
Journal:  Clin Breast Cancer       Date:  2002-04       Impact factor: 3.225

4.  Consumption of vegetables and fruits and risk of breast cancer.

Authors:  Carla H van Gils; Petra H M Peeters; H Bas Bueno-de-Mesquita; Hendriek C Boshuizen; Petra H Lahmann; Françoise Clavel-Chapelon; Anne Thiébaut; Emmanuelle Kesse; Sabina Sieri; Domenico Palli; Rosario Tumino; Salvatore Panico; Paolo Vineis; Carlos A Gonzalez; Eva Ardanaz; Maria-José Sánchez; Pilar Amiano; Carmen Navarro; José R Quirós; Timothy J Key; Naomi Allen; Kay-Tee Khaw; Sheila A Bingham; Theodora Psaltopoulou; Maria Koliva; Antonia Trichopoulou; Gabriële Nagel; Jakob Linseisen; Heiner Boeing; Göran Berglund; Elisabet Wirfält; Göran Hallmans; Per Lenner; Kim Overvad; Anne Tjønneland; Anja Olsen; Eiliv Lund; Dagrun Engeset; Elin Alsaker; Teresa Norat; Rudolf Kaaks; Nadia Slimani; Elio Riboli
Journal:  JAMA       Date:  2005-01-12       Impact factor: 56.272

5.  Age does not predict breast cancer outcome.

Authors:  J P Crowe; N H Gordon; R R Shenk; R M Zollinger; D J Brumberg; J M Shuck
Journal:  Arch Surg       Date:  1994-05

6.  Premenopausal fat intake and risk of breast cancer.

Authors:  Eunyoung Cho; Donna Spiegelman; David J Hunter; Wendy Y Chen; Meir J Stampfer; Graham A Colditz; Walter C Willett
Journal:  J Natl Cancer Inst       Date:  2003-07-16       Impact factor: 13.506

7.  The relation between survival and age at diagnosis in breast cancer.

Authors:  H O Adami; B Malker; L Holmberg; I Persson; B Stone
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

8.  Age as prognostic factor in premenopausal breast carcinoma.

Authors:  A de la Rochefordiere; B Asselain; F Campana; S M Scholl; J Fenton; J R Vilcoq; J C Durand; P Pouillart; H Magdelenat; A Fourquet
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

9.  A prospective study of age-specific physical activity and premenopausal breast cancer.

Authors:  Sonia S Maruti; Walter C Willett; Diane Feskanich; Bernard Rosner; Graham A Colditz
Journal:  J Natl Cancer Inst       Date:  2008-05-13       Impact factor: 13.506

Review 10.  Obesity and breast cancer: a review of the literature.

Authors:  A R Carmichael; T Bates
Journal:  Breast       Date:  2004-04       Impact factor: 4.380

View more
  114 in total

1.  Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age.

Authors:  K A Kaphingst; J Ivanovich; B B Biesecker; R Dresser; J Seo; L G Dressler; P J Goodfellow; M S Goodman
Journal:  Clin Genet       Date:  2015-05-05       Impact factor: 4.438

Review 2.  Diagnostic performance of the automated breast volume scanner: a systematic review of inter-rater reliability/agreement and meta-analysis of diagnostic accuracy for differentiating benign and malignant breast lesions.

Authors:  Zheying Meng; Cui Chen; Yitong Zhu; Shuling Zhang; Cong Wei; Bin Hu; Li Yu; Bing Hu; E Shen
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315

3.  Combined Runx2 and Snail overexpression is associated with a poor prognosis in breast cancer.

Authors:  Zhengjun Yang; Bin Zhang; Bowen Liu; Yegong Xie; Xuchen Cao
Journal:  Tumour Biol       Date:  2015-01-22

4.  Efficacy of capecitabine-based combination therapy and single-agent capecitabine maintenance therapy in patients with metastatic breast cancer.

Authors:  Huimin Lv; Min Yan; Mengwei Zhang; Limin Niu; Huiai Zeng; Shude Cui
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

5.  Neoadjuvant chemotherapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and docetaxel.

Authors:  Xi Gu; Shi Jia; Wei Wei; Wen-Hai Zhang
Journal:  Tumour Biol       Date:  2015-02-15

6.  Breast cancer cases of female patients under 35 years of age in Togo: A series of 158 cases.

Authors:  Tchin Darré; Mazamaesso Tchaou; Koué Folligan; Abdoulatif Amadou; Bidamin N'Timon; Lantam Sonhaye; Abdoul-Samadou Aboubakari; Koffi Amégbor; Koffi Akpadza; Gado Napo Koura
Journal:  Mol Clin Oncol       Date:  2017-10-18

7.  Bioinformatic analysis reveals the key pathways and genes in early-onset breast cancer.

Authors:  Chuanlong Cui; Lun Li; Jing Zhen
Journal:  Med Oncol       Date:  2018-04-11       Impact factor: 3.064

8.  Examining the etiology of early-onset breast cancer in the Canadian Partnership for Tomorrow's Health (CanPath).

Authors:  Joy Pader; Robert B Basmadjian; Dylan E O'Sullivan; Nicole E Mealey; Yibing Ruan; Christine Friedenreich; Rachel Murphy; Edwin Wang; May Lynn Quan; Darren R Brenner
Journal:  Cancer Causes Control       Date:  2021-06-25       Impact factor: 2.506

Review 9.  Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women.

Authors:  Lorenzo Rossi; Olivia Pagani
Journal:  Curr Treat Options Oncol       Date:  2017-05

10.  Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.

Authors:  Yuanting Xiao; Sheng Zhang; Guofang Hou; Xiaobei Zhang; Xiaomeng Hao; Jin Zhang
Journal:  Tumour Biol       Date:  2013-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.